Abbott
Abbott Q4 Diagnostics Revenues Fall 26 Percent on Declining COVID-19 Sales
The company announced that its total revenues for the quarter declined 12 percent, while revenues for the full year rose 1 percent.
JP Morgan Healthcare Conference, Day 2: Labcorp, Abbott, Thermo Fisher Scientific, Roche, More
Highlights from the first day included updates on several firms' COVID testing businesses, and details about a recent Thermo Fisher Scientific acquisition.
Top Five Articles on 360Dx Last Week: Cue Health Layoffs; Handheld Dx Systems Development; and More
Last week, readers were most interested in Cue Health laying off 388 workers, or 26 percent of its staff, to reduce its costs.
Siemens Healthineers, Roche, Beckman Coulter, Abbott Gain FDA 510(k) Clearances in December
The agency cleared tests to help predict cardiovascular disease, rule out causes of Alzheimer's disease, provide early pregnancy detection, and identify prior drug use, among other uses.
Roche, BioMérieux, Abbott Gain FDA 510(k) Clearances in October
The month's clearances included tests for COVID-19, antimicrobial resistance, sexually transmitted infections, fever-causing infections, and blood glucose levels.